IL110239A0 - Azacyclic - heterocyclic compounds as angiotensin II receptor antagonists - Google Patents
Azacyclic - heterocyclic compounds as angiotensin II receptor antagonistsInfo
- Publication number
- IL110239A0 IL110239A0 IL11023994A IL11023994A IL110239A0 IL 110239 A0 IL110239 A0 IL 110239A0 IL 11023994 A IL11023994 A IL 11023994A IL 11023994 A IL11023994 A IL 11023994A IL 110239 A0 IL110239 A0 IL 110239A0
- Authority
- IL
- Israel
- Prior art keywords
- azacyclic
- angiotensin
- receptor antagonists
- heterocyclic compounds
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9234993A | 1993-07-15 | 1993-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL110239A0 true IL110239A0 (en) | 1994-10-21 |
Family
ID=22232802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11023994A IL110239A0 (en) | 1993-07-15 | 1994-07-07 | Azacyclic - heterocyclic compounds as angiotensin II receptor antagonists |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5789415A (fr) |
| AP (1) | AP9400651A0 (fr) |
| AU (1) | AU6979494A (fr) |
| FI (1) | FI943359A (fr) |
| IL (1) | IL110239A0 (fr) |
| MA (1) | MA23268A1 (fr) |
| SI (1) | SI9400291A (fr) |
| WO (1) | WO1995002596A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| JP5082033B2 (ja) | 2001-12-21 | 2012-11-28 | エグゼリクシス パテント カンパニー エルエルシー | Ｌｘｒのモジュレーター |
| WO2005082904A1 (fr) * | 2004-02-26 | 2005-09-09 | Kyowa Hakko Kogyo Co., Ltd. | Agent préventif et/ou thérapeutique pour une maladie inflammatoire neutrophile |
| RS52927B (en) | 2004-12-24 | 2014-02-28 | Spinifex Pharmaceuticals Pty Ltd | TREATMENT OR PROPHYLAX PROCEDURE |
| AU2007229322B2 (en) * | 2006-03-20 | 2012-04-05 | Novartis Ag | Method of treatment or prophylaxis inflammatory pain |
| US7828840B2 (en) * | 2007-11-15 | 2010-11-09 | Med Institute, Inc. | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists |
| EP2630136A1 (fr) * | 2010-10-21 | 2013-08-28 | Universität des Saarlandes | Inhibiteurs sélectifs de cyp11b1 pour le traitement de maladies dépendantes du cortisol |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240928A (en) * | 1989-07-03 | 1993-08-31 | Merck & Co., Inc. | Substituted quinazolinones as angiotensin II antagonists |
| JPH05504969A (ja) * | 1990-02-13 | 1993-07-29 | メルク・エンド・カムパニー・インコーポレーテツド | 置換ベンジル要素を含有するアンギオテンシン２アンタゴニスト類 |
| US5177074A (en) * | 1991-03-26 | 1993-01-05 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| US5151435A (en) * | 1991-04-08 | 1992-09-29 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating an indole or dihydroindole |
| DE4200954A1 (de) * | 1991-04-26 | 1992-10-29 | Bayer Ag | Heterocyclisch substituierte phenylessigsaeurederivate |
| GB9113626D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic compounds |
| GB9113628D0 (en) * | 1991-06-25 | 1991-08-14 | Ici Plc | Heterocyclic derivatives |
| IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
| US5187159A (en) * | 1991-10-07 | 1993-02-16 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole |
| US5283242A (en) * | 1991-10-24 | 1994-02-01 | American Home Products Corporation | Substituted benzimidazoles and quinazolines as antihypertensives |
| US5350752A (en) * | 1991-12-16 | 1994-09-27 | E. R. Squibb & Sons, Inc. | Dihydropyrimidine derivatives |
| US5308853A (en) * | 1991-12-20 | 1994-05-03 | Warner-Lambert Company | Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties |
| US5300668A (en) * | 1993-03-10 | 1994-04-05 | Pfizer Inc. | Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates |
-
1994
- 1994-06-30 AP APAP/P/1994/000651A patent/AP9400651A0/en unknown
- 1994-07-01 AU AU69794/94A patent/AU6979494A/en not_active Abandoned
- 1994-07-01 WO PCT/IB1994/000187 patent/WO1995002596A1/fr active Application Filing
- 1994-07-01 US US08/569,133 patent/US5789415A/en not_active Expired - Fee Related
- 1994-07-07 IL IL11023994A patent/IL110239A0/xx unknown
- 1994-07-14 MA MA23582A patent/MA23268A1/fr unknown
- 1994-07-14 SI SI9400291A patent/SI9400291A/sl unknown
- 1994-07-14 FI FI943359A patent/FI943359A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SI9400291A (en) | 1995-10-31 |
| AP9400651A0 (en) | 1995-12-30 |
| US5789415A (en) | 1998-08-04 |
| MA23268A1 (fr) | 1995-04-01 |
| WO1995002596A1 (fr) | 1995-01-26 |
| AU6979494A (en) | 1995-02-13 |
| FI943359A0 (fi) | 1994-07-14 |
| FI943359A (fi) | 1995-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0475206A3 (en) | Angiotensin ii receptor antagonists | |
| HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
| IL105877A0 (en) | Angiotensin ii antagonists | |
| HU9603525D0 (en) | Vironectin receptor antagonists | |
| GB9405317D0 (en) | Fibrinogen receptor antagonists | |
| IL115613A0 (en) | Bicyclic neuropeptide y receptor antagonists | |
| EP0912175A4 (fr) | Antagonistes du recepteur de fibrinogene | |
| EP0810994A4 (fr) | Antagonistes des recepteurs de fibrinogene | |
| EP0866705A4 (fr) | Antagonistes du recepteur de fibrinogene | |
| AU3276293A (en) | Angiotensin II receptor antagonists | |
| EP0885205A4 (fr) | Antagonistes des recepteurs de fibrinogenes | |
| GB9317760D0 (en) | Angiotensin ii antagonist | |
| EP0885213A4 (fr) | Antagonistes du recepteur du fibrinogene | |
| EP0796098A4 (fr) | Antagonistes des recepteurs du fibrinogene | |
| HU9502028D0 (en) | Fibrinogen receptor antagonists | |
| GB9317758D0 (en) | Angiotensin ii antagonist | |
| EP0801650A4 (fr) | Antagonistes des recepteurs du fibrinogene | |
| GB9320799D0 (en) | Fibrinogen receptor antagonists | |
| EP0794779A4 (fr) | Antagonistes des recepteurs du fibrinogene | |
| IL110239A0 (en) | Azacyclic - heterocyclic compounds as angiotensin II receptor antagonists | |
| GB9515852D0 (en) | Fibrinogen receptor antagonists | |
| EP0546449A3 (en) | Benzofuranderivatives as angiotensin ii antagonists | |
| IL108843A0 (en) | Benzylimidazopyridine derivative as angiotensin II receptor antagonist | |
| EP0800395A4 (fr) | Antagonistes des recepteurs du fibrinogene | |
| AU4348593A (en) | Chromanderivatives as angiotensin ii antagonists |